Starting GLP-1 Weight Management in Florida: What the Initial Evaluation Covers

By Desirae Bloomquist, MSN, FNP-C, MSCP

You may have spent months thinking about weight-loss medication before making an appointment. Perhaps your usual routines no longer seem to work, or you want to understand whether medical support could help. You can bring those questions to a visit without already knowing which treatment you want.

An initial GLP-1 weight-management evaluation reviews your weight history, overall health, medications, treatment goals, and any testing needed to guide care. For patients seeking care online in Florida, it also provides an opportunity to discuss how follow-up, local testing, and communication will work.

Your history matters more than a single number

A useful conversation starts with what has changed. When did weight become a concern? What have you tried, what helped, and what was difficult to sustain?

Your clinician may also ask about sleep, eating patterns, physical activity, stress, and how your weight affects everyday life. In midlife, mention changes in your periods or menopause symptoms too. These details belong in the conversation even when weight management is your main reason for seeking care.

A comprehensive evaluation considers previous treatment, contributing factors, other health conditions, and barriers to care. That broader approach is reflected in the 2026 Standards of Care in Overweight and Obesity.

Is GLP-1 treatment appropriate for you?

Medication decisions depend on the specific treatment, your health history, and the balance of potential benefits and risks. A consultation does not guarantee a prescription.

Bring a complete medication list, including supplements and any previous weight-loss treatments. Explain why you stopped earlier medications, especially if side effects were involved. Your clinician also needs to know about allergies, pregnancy plans, and breastfeeding. Weight-loss medicines should not be used during pregnancy. The National Institute of Diabetes and Digestive and Kidney Diseases explains how current conditions, other medicines, family history, and cost inform treatment choices.

Some safety questions are specific to the medicine being considered. For example, Zepbound (tirzepatide), which acts on both GIP and GLP-1 receptors, must not be used by people with a personal or family history of medullary thyroid carcinoma or MEN2, or a serious allergy to its ingredients. Its prescribing information also addresses severe stomach-emptying problems, pancreatitis, gallbladder disease, and other risks.

Tell your clinician if you use an oral contraceptive: tirzepatide can reduce its effectiveness, requiring an additional barrier method or a switch to non-oral contraception for four weeks after starting and after each dose increase. These are examples of why an individual medication review matters. Zepbound prescribing information.

Will you need labs before starting?

Your clinician will review available results and decide what additional information is needed. Assessment may include height, weight, blood pressure, blood sugar or A1C, cholesterol, and kidney or liver function. Other testing depends on symptoms and medical history; everyone does not necessarily need the same panel.

The Obesity Medicine Association’s evaluation guidance supports tailoring diagnostic testing to the person’s presentation and clinical judgment.

Bring recent results if you have them. For an online visit, ask how measurements will be obtained and where any necessary lab work or in-person examination can be completed. Having a video appointment does not eliminate the need for those steps when clinically appropriate.

What should you understand before treatment begins?

Leave with a clear explanation of the proposed plan and an opportunity to ask questions:

  • Which medication are we considering, and why does it fit my situation?

  • What side effects should I expect, and which symptoms need prompt attention?

  • When will we follow up, and how do I contact you between visits?

  • What nutrition and movement support will help me during treatment?

  • What will membership, medication, and testing cost separately?

Weight-management medication works alongside nutrition and physical activity. Treatment may continue long term, with reassessment of benefits, tolerability, and goals. Discuss that possibility at the beginning rather than assuming a short course will be enough. NIDDK guidance on weight-management medicines.

Starting weight-management care in Florida

Heat Wave Health offers telehealth care for patients in Florida. Our standalone Weight Loss and GLP-1 Management membership includes clinical evaluation, prescribing when appropriate, virtual follow-up, secure messaging with Desirae, nutrition and lifestyle guidance, and interpretation of testing ordered when indicated.

You do not need a Comprehensive Membership to access this service. Medications and lab testing are billed separately; current membership details are available below.

If you are unsure where to begin, request a free consult to discuss getting started. The consult request asks our team to contact you; it does not instantly book an appointment or replace the clinical evaluation.

Explore Weight Management Membership

Request a Free Consult

Desirae Bloomquist, MSN, FNP-C, MSCP

Desirae Bloomquist, MSN, FNP-C, MSCP, is a board-certified family nurse practitioner and Menopause Society Certified Practitioner at Heat Wave Health. She provides personalized telehealth care for women navigating perimenopause, menopause, and midlife in Washington, Illinois, and Oregon. Her approach combines evidence-based medicine with thoughtful listening and care tailored to each patient’s symptoms, priorities, and goals.

https://www.heatwavehealth.com/
Previous
Previous

Menopause and Joint Pain: What the Evidence Says—and What Can Help

Next
Next

Brain Fog in Perimenopause: What to Discuss With a Clinician